|
(P358) |
Hyperglycemia drives functional expression of the PAR4 thrombin receptor in cardiac fibroblasts |
| |
|
A. Fender, S. Kleeschulte, D. Gorski, J. Schmitt, K. Schrör (Münster, Düsseldorf) |
|
(P359) |
Fibroblast growth factor 23 targets cardiac fibroblasts leading to fibroblast activation and myocardial fibrosis at least partially by activation of local renin-angiotensin-aldosterone system |
| |
|
M. Leifheit-Nestler, I. Böckmann, N. Zeaiter, J. Nespor, B. Richter, F. Kirchhoff, J. Heineke, D. Haffner (Hannover; Birmingham, US) |
|
(P360) |
Fibroblast-mediated atrial mechanical dysfunction in HFpEF and hypertensive heart disease |
| |
|
D. Bode, S. Reimers, R. Dörr, D. Lindner, M. Schwarzl, D. Westermann, U. Primessnig, B. Pieske, F. R. Heinzel, F. Hohendanner (Berlin, Hamburg) |
|
(P361) |
ERK1/2 autophosphorylation at threonine 188 in cardiac fibroblasts contributes to maladaptive remodeling of the heart in response to chronic pressure overload |
| |
|
J. Teloh, O. Wiens, N. Eppli, K. Lorenz (Dortmund, Würzburg) |
|
(P362) |
Reduktion der kardialen Fibrose und Verbesserung der Herzfunktion durch Inhibierung des Transkriptionsfaktors Sox9 in kardialen Fibroblasten |
| |
|
G. M. Scharf, K. Kilian, N. Froese, Y. Wang, K. C. Wollert, J. Bauersachs, J. Heineke (Hannover) |
|
(P363) |
A novel technique for the isolation of highly purified cardiac fibroblasts from the murine heart |
| |
|
C. Owenier, C. Alter, J. Hesse, J. Schrader (Düsseldorf) |